Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance.

Wang H, El Maadidi S, Fischer J, Grabski E, Dickhöfer S, Klimosch S, Flannery SM, Filomena A, Wolz OO, Schneiderhan-Marra N, Löffler MW, Wiese M, Pichulik T, Müllhaupt B, Semela D, Dufour JF, Bochud PY, Bowie AG, Kalinke U, Berg T, Weber AN; East-German and Swiss Hepatitis C Virus Study Groups.

Hepatology. 2015 Nov;62(5):1375-87. doi: 10.1002/hep.28105. Epub 2015 Sep 28.

PMID:
26250868
2.

Evaluation of liver disease progression in the German hepatitis C virus (1b)-contaminated anti-D cohort at 35 years after infection.

Wiese M, Fischer J, Löbermann M, Göbel U, Grüngreiff K, Güthoff W, Kullig U, Richter F, Schiefke I, Tenckhoff H, Zipprich A, Berg T, Müller T; East German HCV Study Group.

Hepatology. 2014 Jan;59(1):49-57. doi: 10.1002/hep.26644. Epub 2013 Nov 18. Erratum in: Hepatology. 2015 Apr;61(4):1446-7.

PMID:
23929603
3.

Susceptibility to chronic hepatitis C virus infection is influenced by sequence differences in immunodominant CD8+ T cell epitopes.

Ziegler S, Ruhl M, Tenckhoff H, Wiese M, Heinemann FM, Horn PA, Spengler U, Neumann-Haefelin C, Nattermann J, Timm J; East-German HCV Study Group.

J Hepatol. 2013 Jan;58(1):24-30. doi: 10.1016/j.jhep.2012.08.016. Epub 2012 Aug 25.

PMID:
22925811
4.

CD8+ T-cell response promotes evolution of hepatitis C virus nonstructural proteins.

Ruhl M, Knuschke T, Schewior K, Glavinic L, Neumann-Haefelin C, Chang DI, Klein M, Heinemann FM, Tenckhoff H, Wiese M, Horn PA, Viazov S, Spengler U, Roggendorf M, Scherbaum N, Nattermann J, Hoffmann D, Timm J; East German HCV Study Group.

Gastroenterology. 2011 Jun;140(7):2064-73. doi: 10.1053/j.gastro.2011.02.060. Epub 2011 Mar 2.

PMID:
21376049
5.

A polymorphism near IL28B is associated with spontaneous clearance of acute hepatitis C virus and jaundice.

Tillmann HL, Thompson AJ, Patel K, Wiese M, Tenckhoff H, Nischalke HD, Lokhnygina Y, Kullig U, Göbel U, Capka E, Wiegand J, Schiefke I, Güthoff W, Grüngreiff K, König I, Spengler U, McCarthy J, Shianna KV, Goldstein DB, McHutchison JG, Timm J, Nattermann J; German Anti-D Study Group.

Gastroenterology. 2010 Nov;139(5):1586-92, 1592.e1. doi: 10.1053/j.gastro.2010.07.005. Epub 2010 Jul 14.

PMID:
20637200
6.

Outcome in a hepatitis C (genotype 1b) single source outbreak in Germany--a 25-year multicenter study.

Wiese M, Grüngreiff K, Güthoff W, Lafrenz M, Oesen U, Porst H; East German Hepatitis C Study Group.

J Hepatol. 2005 Oct;43(4):590-8.

PMID:
16237783
7.

Sequential combination therapy of HBe antigen-negative/virus-DNA-positive chronic hepatitis B with famciclovir or lamivudine and interferon-alpha-2a.

Schiefke I, Klecker C, Maier M, Oesen U, Etzrodt G, Tannapfel A, Liebert UG, Berr F.

Liver Int. 2004 Apr;24(2):98-104.

PMID:
15078472
8.

Low frequency of cirrhosis in a hepatitis C (genotype 1b) single-source outbreak in germany: a 20-year multicenter study.

Wiese M, Berr F, Lafrenz M, Porst H, Oesen U.

Hepatology. 2000 Jul;32(1):91-6.

PMID:
10869294
9.

Decreased immunogenicity of recombinant hepatitis B vaccine in chronic hepatitis C.

Wiedmann M, Liebert UG, Oesen U, Porst H, Wiese M, Schroeder S, Halm U, Mössner J, Berr F.

Hepatology. 2000 Jan;31(1):230-4.

PMID:
10613751

Supplemental Content

Loading ...
Support Center